ALR Technologies Inc.
- Market Cap (Standard market cap (price × shares outstanding) from the company profile — shown because the screener's float-computed cap is unavailable for this ticker.)
- $10.8M
- Volume
- 24.1K
Market cap as of May 8, 2026, 11:30 AM ET
About
ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials. The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies designed to provide continuous blood sugar readings. Addressing a specific need in veterinary medicine, ALR Technologies offers the GluCurve Pet CGM, tailored for diabetic felines and canines, and utilized by veterinarians. Furthermore, their Prediabetes System supports patients with educational video content, supplementary resources optimized for mobile devices, and a private online community for discussing disease management strategies. ALR Technologies primarily serves healthcare providers, health insurance companies, and entities specializing in disease and case management services, including those within the home care industry. Originally incorporated in 1987 as Mo Betta Corp., the company rebranded to ALR Technologies Inc. in December 1998. It is based in Richmond, Virginia, and operates as a subsidiary of ALR Technologies SG Ltd.
Quick stats
Shares outstanding645.5M
Computed float256.5M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001930419
Websitehttps://www.alrt.com
AI Summary
AI-generated9d agomajorbullishm and aALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
ALR Technologies signed a Letter of Intent to acquire CGM Medical Technology for an aggregate of 200 million ordinary shares and US$45 million, aiming to vertically integrate its diabetes management operations.
The deal includes acquiring the Singapore entity for shares and a US$40 million promissory note, plus the Shenzhen assets for up to US$5 million in cash.
Consideration is heavily performance-based, with payments tied to free cash flow generation once manufacturing facilities reach rated production capacities of 300,000 to 500,000 CGM units per month.
Red flags
- Deal announced as non-binding Letter of Intent (LOI) subject to due diligence and definitive agreements.
- US$40 million of purchase price is an unsecured, non-interest-bearing promissory note payable from future free cash flow.
- Transaction involves issuance of 200 million ordinary shares, creating significant potential dilution.